New Feature
  • New: Financial Statement (Balance Sheet, Income Statement & Cash Flow)
  • New: Go to Stock Page (E.g FRONTKN) > Financial Highlights Section
  • New: Financial Statement (Balance Sheet, Income Statement & Cash Flow)
  • New: Go to Stock Page (E.g FRONTKN) > Financial Highlights Section
VIEW SAMPLE
add free Download App
premium Premium Account

Last Price Change Volume
Open: Day Range: Prev Close:


WINDING UP / RECEIVER & MANAGER / RESTRAINING ORDER / SPECIAL ADMINISTRATOR - TMC LIFE SCIENCES BERHAD ('TMCLS' OR 'THE COMPANY') COMMENCEMENT OF MEMBER'S VOLUNTARY WINDING-UP OF WHOLLY-OWNED SUBSIDIARY, TMC BIOTECH SDN. BHD. ('TMCB')

TMC LIFE SCIENCES BERHAD

Type Announcement
Subject WINDING UP / RECEIVER & MANAGER / RESTRAINING ORDER / SPECIAL ADMINISTRATOR
Description
- TMC LIFE SCIENCES BERHAD ('TMCLS' OR 'THE COMPANY')  COMMENCEMENT OF MEMBER'S VOLUNTARY WINDING-UP OF WHOLLY-OWNED SUBSIDIARY, TMC BIOTECH SDN. BHD. ('TMCB')

The Board of Directors of TMCLS wishes to inform that its wholly-owned subsidiary, TMCB had on 19 September 2022 commenced its member’s voluntary winding-up (‘Winding-Up’) pursuant to Section 439(1)(b) of the Companies Act 2016. Ms. Chua Siew Chuan and Ms. Chin Mun Yee of Securities Services (Holdings) Sdn. Bhd. were appointed as Liquidators for the Winding-Up.

 

Details of the wholly-owned subsidiary under Winding-Up are as follows:-

 

Name

Date of Incorporation

Principal Activity

Paid-up Share Capital

Remark

TMCB

31 May 2007

TMCB was previously engaged in the provision of fertility consultancy, laboratory & embryology services and research and development services. TMCB has ceased its business operations and remained dormant.

RM50,000

TMCB is a wholly-owned subsidiary of TMCLS.

 

 

 

The Winding-Up is part of the Company’s streamlining exercise to simplify the Group structure and improve efficiency within the Group. In addition, the Winding-Up will enable the Group to save future costs associated with maintaining the inactive subsidiary.

 

The Winding-Up will not have any material effect on the earnings, net assets and gearing of the Group for the financial year ending 30 June 2023, and will not have any effect on the issued share capital and substantial shareholders’ shareholdings of TMCLS.

 

None of the Directors or major shareholders of the Company, or any person connected to them, has any interest, direct or indirect, in the Winding-Up.

 

This announcement is dated 19 September 2022.






Announcement Info

Company Name TMC LIFE SCIENCES BERHAD
Stock Name TMCLIFE
Date Announced 19 Sep 2022
Category General Announcement for PLC
Reference Number GA1-23052022-00054




Close